These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 29923305

  • 1. Efficacy of a novel herbal formulation for weight loss demonstrated in a 16-week randomized, double-blind, placebo-controlled clinical trial with healthy overweight adults.
    Dixit K, Kamath DV, Alluri KV, Davis BA.
    Diabetes Obes Metab; 2018 Nov; 20(11):2633-2641. PubMed ID: 29923305
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study.
    Sengupta K, Mishra AT, Rao MK, Sarma KV, Krishnaraju AV, Trimurtulu G.
    Lipids Health Dis; 2012 Sep 20; 11():122. PubMed ID: 22995673
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects.
    Kudiganti V, Kodur RR, Kodur SR, Halemane M, Deep DK.
    Lipids Health Dis; 2016 Aug 24; 15(1):136. PubMed ID: 27558585
    [Abstract] [Full Text] [Related]

  • 4. Combined extracts of Moringa oleifera, Murraya koeingii leaves, and Curcuma longa rhizome increases energy expenditure and controls obesity in high-fat diet-fed rats.
    Kundimi S, Kavungala KC, Sinha S, Tayi VNR, Kundurthi NR, Golakoti T, Davis B, Sengupta K.
    Lipids Health Dis; 2020 Aug 28; 19(1):198. PubMed ID: 32859217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
    Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group.
    JAMA; 2006 Feb 15; 295(7):761-75. PubMed ID: 16478899
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of a novel herbal formulation for weight management.
    Stern JS, Peerson J, Mishra AT, Sadasiva Rao MV, Rajeswari KP.
    Obesity (Silver Spring); 2013 May 15; 21(5):921-7. PubMed ID: 23784895
    [Abstract] [Full Text] [Related]

  • 8. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation.
    Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE.
    Lipids Health Dis; 2009 Mar 02; 8():7. PubMed ID: 19254366
    [Abstract] [Full Text] [Related]

  • 9. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E, Kolanowski J, Scheen A, Van Gaal L, ObelHyx Study Group.
    Int J Obes Relat Metab Disord; 2001 Nov 02; 25(11):1713-21. PubMed ID: 11753595
    [Abstract] [Full Text] [Related]

  • 10. Effect of a herbal extract powder (YY-312) from Imperata cylindrica Beauvois, Citrus unshiu Markovich, and Evodia officinalis Dode on body fat mass in overweight adults: a 12-week, randomized, double-blind, placebo-controlled, parallel-group clinical trial.
    Cho YG, Jung JH, Kang JH, Kwon JS, Yu SP, Baik TG.
    BMC Complement Altern Med; 2017 Jul 28; 17(1):375. PubMed ID: 28754119
    [Abstract] [Full Text] [Related]

  • 11. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome.
    Oben J, Kuate D, Agbor G, Momo C, Talla X.
    Lipids Health Dis; 2006 Sep 02; 5():24. PubMed ID: 16948861
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of an herbal formulation for weight management.
    Stern JS, Peerson J, Mishra AT, Mathukumalli VS, Konda PR.
    J Med Food; 2013 Jun 02; 16(6):529-37. PubMed ID: 23767862
    [Abstract] [Full Text] [Related]

  • 14. A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.
    Grube B, Chong PW, Lau KZ, Orzechowski HD.
    Obesity (Silver Spring); 2013 Jan 02; 21(1):58-64. PubMed ID: 23505169
    [Abstract] [Full Text] [Related]

  • 15. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
    Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, Lingvay I, Mosenzon O, Rosenstock J, Rubio MA, Rudofsky G, Tadayon S, Wadden TA, Dicker D, STEP 4 Investigators.
    JAMA; 2021 Apr 13; 325(14):1414-1425. PubMed ID: 33755728
    [Abstract] [Full Text] [Related]

  • 16. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E, COR-I Study Group.
    Lancet; 2010 Aug 21; 376(9741):595-605. PubMed ID: 20673995
    [Abstract] [Full Text] [Related]

  • 17. Safety and toxicological evaluation of a novel anti-obesity formulation LI85008F in animals.
    Krishnaraju AV, Sundararaju D, Srinivas P, Rao CV, Sengupta K, Trimurtulu G.
    Toxicol Mech Methods; 2010 Feb 21; 20(2):59-68. PubMed ID: 20158386
    [Abstract] [Full Text] [Related]

  • 18. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM, Franciscy DM, Wagner HR, Krishnan KR.
    JAMA; 2003 Apr 09; 289(14):1820-5. PubMed ID: 12684361
    [Abstract] [Full Text] [Related]

  • 19. Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study.
    Grube B, Chong PW, Alt F, Uebelhack R.
    J Obes; 2015 Apr 09; 2015():953138. PubMed ID: 26435849
    [Abstract] [Full Text] [Related]

  • 20. Twelve weeks CLA supplementation decreases the hip circumference in overweight and obese women. A double-blind, randomized, placebo-controlled trial.
    Mądry E, Chudzicka-Strugała I, Grabańska-Martyńska K, Malikowska K, Grebowiec P, Lisowska A, Bogdański P, Walkowiak J.
    Acta Sci Pol Technol Aliment; 2016 Apr 09; 15(1):107-113. PubMed ID: 28071044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.